HighTower Advisors’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$43K Hold
20,796
﹤0.01% 3512
2025
Q1
$45.8K Buy
20,796
+4,568
+28% +$10.1K ﹤0.01% 3414
2024
Q4
$24.8K Sell
16,228
-500
-3% -$765 ﹤0.01% 3443
2024
Q3
$34K Buy
16,728
+4,199
+34% +$8.54K ﹤0.01% 3397
2024
Q2
$45K Sell
12,529
-30,000
-71% -$108K ﹤0.01% 3268
2024
Q1
$120K Sell
42,529
-30,032
-41% -$84.7K ﹤0.01% 3084
2023
Q4
$122K Buy
72,561
+61,801
+574% +$104K ﹤0.01% 3118
2023
Q3
$11K Buy
+10,760
New +$11K ﹤0.01% 3278
2020
Q3
Sell
-9,822
Closed -$145K 2359
2020
Q2
$145K Buy
+9,822
New +$145K ﹤0.01% 2033
2020
Q1
Sell
-12,362
Closed -$290K 2171
2019
Q4
$290K Buy
12,362
+457
+4% +$10.7K ﹤0.01% 1738
2019
Q3
$223K Buy
11,905
+974
+9% +$18.2K ﹤0.01% 1990
2019
Q2
$205K Sell
10,931
-4,396
-29% -$82.4K ﹤0.01% 2035
2019
Q1
$373K Sell
15,327
-2,988
-16% -$72.7K ﹤0.01% 1611
2018
Q4
$477K Buy
18,315
+62
+0.3% +$1.62K ﹤0.01% 1376
2018
Q3
$576K Sell
18,253
-1,000
-5% -$31.6K ﹤0.01% 1392
2018
Q2
$749K Sell
19,253
-951
-5% -$37K 0.01% 1260
2018
Q1
$560K Sell
20,204
-8,675
-30% -$240K ﹤0.01% 1353
2017
Q4
$522K Buy
28,879
+8,495
+42% +$154K ﹤0.01% 1426
2017
Q3
$327K Buy
20,384
+3,800
+23% +$61K ﹤0.01% 1643
2017
Q2
$231K Buy
16,584
+1,700
+11% +$23.7K ﹤0.01% 1771
2017
Q1
$225K Hold
14,884
﹤0.01% 1702
2016
Q4
$196K Sell
14,884
-7,300
-33% -$96.1K ﹤0.01% 1684
2016
Q3
$380K Buy
22,184
+4,280
+24% +$73.3K ﹤0.01% 1358
2016
Q2
$322K Buy
17,904
+37
+0.2% +$665 ﹤0.01% 1294
2016
Q1
$340K Sell
17,867
-2,750
-13% -$52.3K ﹤0.01% 1489
2015
Q4
$550K Sell
20,617
-5,094
-20% -$136K 0.01% 1264
2015
Q3
$627K Buy
25,711
+16,443
+177% +$401K 0.01% 1109
2015
Q2
$289K Buy
+9,268
New +$289K ﹤0.01% 1210